Protecting First Responders January 9, 2016 • admin • Keeping our heroes safe from the dangers of chemical exposures. Related News Master License Agreement Signed with University of Maryland Baltimore for the use of galantamine as a treatment for organophosphate poisoning July 12, 2007 Countervail Corporation Awarded Additional $343,000 SBIR Phase II Grant for Continued Development of Medical Countermeasure to Nerve Agents September 9, 2013
